CLINICAL AND MICROBIOLOGICAL FEATURES OF BRANHAMELLA CATARRHALIS BRONCHOPULMONARY INFECTIONS
Branhamella catarrhalis bronchopulmonary infection was diagnosed in 101 patients with clinical lower respiratory tract infections by the presence of gram-negative intracellular diplococci in sputum and growth of more than 20 colonies of B catarrhalis in quantitative culture at a 10-7 dilution. 94 pa...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 1984-04, Vol.323 (8380), p.782-783 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 783 |
|---|---|
| container_issue | 8380 |
| container_start_page | 782 |
| container_title | The Lancet (British edition) |
| container_volume | 323 |
| creator | Slevin, NicholasJ Aitken, John Thornley, PeterE |
| description | Branhamella catarrhalis bronchopulmonary infection was diagnosed in 101 patients with clinical lower respiratory tract infections by the presence of gram-negative intracellular diplococci in sputum and growth of more than 20 colonies of B catarrhalis in quantitative culture at a 10-7 dilution. 94 patients had either chronic chest disease or were current or previous smokers, 59 had a cause of generalised immunosuppression, and 17 had a high risk of aspiration from the oropharynx. The pathogenicity of B catarrhalis was evident from purulence of sputum, fever, blood leucocytosis, and patchy pulmonary shadowing on chest radiographs. B catarrhalis infection contributed to 4 of 6 deaths. B catarrhalis was the only bacterial pathogen isolated from the sputum of 71 patients and it was isolated with other recognised bacterial pathogens from 30 patients. All 10 isolates of B catarrhalis tested were sensitive to oxytetracycline, all 82 tested were sensitive to cefuroxime, 93 of 96 were sensitive to erythromycin, and 85 of 95 to cotrimoxazole. Beta-lactamase was produced by 38 of 99 isolates of B catarrhalis. |
| doi_str_mv | 10.1016/S0140-6736(84)91288-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2209513599</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673684912881</els_id><sourcerecordid>2209513599</sourcerecordid><originalsourceid>FETCH-LOGICAL-c279t-7c343cb4aec0e8bf729d00cc1011e21f1818767e9d4f95a16d579318b1714ff13</originalsourceid><addsrcrecordid>eNqFkF9LwzAUxYMoOKcfQSjogz5Uc9u0SZ4kq60rdK10GygIoUtT6NBtJpvgt7f7w159unA493c4B6FrwA-AIXwcYyDYDakf3jFyz8FjzIUT1ANCiRsQ-naKekfLObqwdo4xJiEOeugjytI8jUTmiPzZGaVRWQzSIitedloSi8m0jMdOkTiDUuRDMYqzTDiRmIiyHIosHXd6kUfD4nWajYpclO9OmidxNEmLfHyJzprq0-qrw-2jaRJPoqF74LvKo3ztUuUTX81IpRXWbNZQj9cYK9WVA-1BAwwYDanmNWl4UEFYB5T7wGZAgTQN-H10s-euzPJ7o-1azpcbs-gipedhHoAfcN65gr1LmaW1RjdyZdqvyvxKwHI7pNwNKbcrSUbkbki5pd8e6JVV1WdjqoVq7fGZh4BDtsU_7W26a_rTaiOtavVC6bo1Wq1lvWz_CfoD1H5-GQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2209513599</pqid></control><display><type>article</type><title>CLINICAL AND MICROBIOLOGICAL FEATURES OF BRANHAMELLA CATARRHALIS BRONCHOPULMONARY INFECTIONS</title><source>Elsevier ScienceDirect Journals</source><creator>Slevin, NicholasJ ; Aitken, John ; Thornley, PeterE</creator><creatorcontrib>Slevin, NicholasJ ; Aitken, John ; Thornley, PeterE</creatorcontrib><description>Branhamella catarrhalis bronchopulmonary infection was diagnosed in 101 patients with clinical lower respiratory tract infections by the presence of gram-negative intracellular diplococci in sputum and growth of more than 20 colonies of B catarrhalis in quantitative culture at a 10-7 dilution. 94 patients had either chronic chest disease or were current or previous smokers, 59 had a cause of generalised immunosuppression, and 17 had a high risk of aspiration from the oropharynx. The pathogenicity of B catarrhalis was evident from purulence of sputum, fever, blood leucocytosis, and patchy pulmonary shadowing on chest radiographs. B catarrhalis infection contributed to 4 of 6 deaths. B catarrhalis was the only bacterial pathogen isolated from the sputum of 71 patients and it was isolated with other recognised bacterial pathogens from 30 patients. All 10 isolates of B catarrhalis tested were sensitive to oxytetracycline, all 82 tested were sensitive to cefuroxime, 93 of 96 were sensitive to erythromycin, and 85 of 95 to cotrimoxazole. Beta-lactamase was produced by 38 of 99 isolates of B catarrhalis.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(84)91288-1</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Antibiotics ; Bacterial diseases ; Bacterial diseases of the respiratory system ; Biological and medical sciences ; Blood ; Bronchopulmonary infection ; Cefuroxime ; Chest ; Cotrimoxazole ; Dilution ; Erythromycin ; Fever ; Hospitals ; Human bacterial diseases ; Immunosuppression ; Infections ; Infectious diseases ; Medical sciences ; Oropharynx ; Oxytetracycline ; Pathogenicity ; Pathogens ; Patients ; Pediatrics ; Radiographs ; Radiography ; Respiratory tract ; Respiratory tract diseases ; Sputum ; Tumors ; β Lactamase</subject><ispartof>The Lancet (British edition), 1984-04, Vol.323 (8380), p.782-783</ispartof><rights>1984</rights><rights>1984 INIST-CNRS</rights><rights>Copyright Elsevier Limited Apr 7, 1984</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c279t-7c343cb4aec0e8bf729d00cc1011e21f1818767e9d4f95a16d579318b1714ff13</citedby><cites>FETCH-LOGICAL-c279t-7c343cb4aec0e8bf729d00cc1011e21f1818767e9d4f95a16d579318b1714ff13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0140673684912881$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9610689$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Slevin, NicholasJ</creatorcontrib><creatorcontrib>Aitken, John</creatorcontrib><creatorcontrib>Thornley, PeterE</creatorcontrib><title>CLINICAL AND MICROBIOLOGICAL FEATURES OF BRANHAMELLA CATARRHALIS BRONCHOPULMONARY INFECTIONS</title><title>The Lancet (British edition)</title><description>Branhamella catarrhalis bronchopulmonary infection was diagnosed in 101 patients with clinical lower respiratory tract infections by the presence of gram-negative intracellular diplococci in sputum and growth of more than 20 colonies of B catarrhalis in quantitative culture at a 10-7 dilution. 94 patients had either chronic chest disease or were current or previous smokers, 59 had a cause of generalised immunosuppression, and 17 had a high risk of aspiration from the oropharynx. The pathogenicity of B catarrhalis was evident from purulence of sputum, fever, blood leucocytosis, and patchy pulmonary shadowing on chest radiographs. B catarrhalis infection contributed to 4 of 6 deaths. B catarrhalis was the only bacterial pathogen isolated from the sputum of 71 patients and it was isolated with other recognised bacterial pathogens from 30 patients. All 10 isolates of B catarrhalis tested were sensitive to oxytetracycline, all 82 tested were sensitive to cefuroxime, 93 of 96 were sensitive to erythromycin, and 85 of 95 to cotrimoxazole. Beta-lactamase was produced by 38 of 99 isolates of B catarrhalis.</description><subject>Antibiotics</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the respiratory system</subject><subject>Biological and medical sciences</subject><subject>Blood</subject><subject>Bronchopulmonary infection</subject><subject>Cefuroxime</subject><subject>Chest</subject><subject>Cotrimoxazole</subject><subject>Dilution</subject><subject>Erythromycin</subject><subject>Fever</subject><subject>Hospitals</subject><subject>Human bacterial diseases</subject><subject>Immunosuppression</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Oropharynx</subject><subject>Oxytetracycline</subject><subject>Pathogenicity</subject><subject>Pathogens</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Radiographs</subject><subject>Radiography</subject><subject>Respiratory tract</subject><subject>Respiratory tract diseases</subject><subject>Sputum</subject><subject>Tumors</subject><subject>β Lactamase</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><recordid>eNqFkF9LwzAUxYMoOKcfQSjogz5Uc9u0SZ4kq60rdK10GygIoUtT6NBtJpvgt7f7w159unA493c4B6FrwA-AIXwcYyDYDakf3jFyz8FjzIUT1ANCiRsQ-naKekfLObqwdo4xJiEOeugjytI8jUTmiPzZGaVRWQzSIitedloSi8m0jMdOkTiDUuRDMYqzTDiRmIiyHIosHXd6kUfD4nWajYpclO9OmidxNEmLfHyJzprq0-qrw-2jaRJPoqF74LvKo3ztUuUTX81IpRXWbNZQj9cYK9WVA-1BAwwYDanmNWl4UEFYB5T7wGZAgTQN-H10s-euzPJ7o-1azpcbs-gipedhHoAfcN65gr1LmaW1RjdyZdqvyvxKwHI7pNwNKbcrSUbkbki5pd8e6JVV1WdjqoVq7fGZh4BDtsU_7W26a_rTaiOtavVC6bo1Wq1lvWz_CfoD1H5-GQ</recordid><startdate>19840407</startdate><enddate>19840407</enddate><creator>Slevin, NicholasJ</creator><creator>Aitken, John</creator><creator>Thornley, PeterE</creator><general>Elsevier Ltd</general><general>Lancet</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>ASE</scope><scope>C1K</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>KB~</scope><scope>M7N</scope><scope>NAPCQ</scope></search><sort><creationdate>19840407</creationdate><title>CLINICAL AND MICROBIOLOGICAL FEATURES OF BRANHAMELLA CATARRHALIS BRONCHOPULMONARY INFECTIONS</title><author>Slevin, NicholasJ ; Aitken, John ; Thornley, PeterE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c279t-7c343cb4aec0e8bf729d00cc1011e21f1818767e9d4f95a16d579318b1714ff13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Antibiotics</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the respiratory system</topic><topic>Biological and medical sciences</topic><topic>Blood</topic><topic>Bronchopulmonary infection</topic><topic>Cefuroxime</topic><topic>Chest</topic><topic>Cotrimoxazole</topic><topic>Dilution</topic><topic>Erythromycin</topic><topic>Fever</topic><topic>Hospitals</topic><topic>Human bacterial diseases</topic><topic>Immunosuppression</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Oropharynx</topic><topic>Oxytetracycline</topic><topic>Pathogenicity</topic><topic>Pathogens</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Radiographs</topic><topic>Radiography</topic><topic>Respiratory tract</topic><topic>Respiratory tract diseases</topic><topic>Sputum</topic><topic>Tumors</topic><topic>β Lactamase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Slevin, NicholasJ</creatorcontrib><creatorcontrib>Aitken, John</creatorcontrib><creatorcontrib>Thornley, PeterE</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Newsstand Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Slevin, NicholasJ</au><au>Aitken, John</au><au>Thornley, PeterE</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CLINICAL AND MICROBIOLOGICAL FEATURES OF BRANHAMELLA CATARRHALIS BRONCHOPULMONARY INFECTIONS</atitle><jtitle>The Lancet (British edition)</jtitle><date>1984-04-07</date><risdate>1984</risdate><volume>323</volume><issue>8380</issue><spage>782</spage><epage>783</epage><pages>782-783</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Branhamella catarrhalis bronchopulmonary infection was diagnosed in 101 patients with clinical lower respiratory tract infections by the presence of gram-negative intracellular diplococci in sputum and growth of more than 20 colonies of B catarrhalis in quantitative culture at a 10-7 dilution. 94 patients had either chronic chest disease or were current or previous smokers, 59 had a cause of generalised immunosuppression, and 17 had a high risk of aspiration from the oropharynx. The pathogenicity of B catarrhalis was evident from purulence of sputum, fever, blood leucocytosis, and patchy pulmonary shadowing on chest radiographs. B catarrhalis infection contributed to 4 of 6 deaths. B catarrhalis was the only bacterial pathogen isolated from the sputum of 71 patients and it was isolated with other recognised bacterial pathogens from 30 patients. All 10 isolates of B catarrhalis tested were sensitive to oxytetracycline, all 82 tested were sensitive to cefuroxime, 93 of 96 were sensitive to erythromycin, and 85 of 95 to cotrimoxazole. Beta-lactamase was produced by 38 of 99 isolates of B catarrhalis.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><doi>10.1016/S0140-6736(84)91288-1</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 1984-04, Vol.323 (8380), p.782-783 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_journals_2209513599 |
| source | Elsevier ScienceDirect Journals |
| subjects | Antibiotics Bacterial diseases Bacterial diseases of the respiratory system Biological and medical sciences Blood Bronchopulmonary infection Cefuroxime Chest Cotrimoxazole Dilution Erythromycin Fever Hospitals Human bacterial diseases Immunosuppression Infections Infectious diseases Medical sciences Oropharynx Oxytetracycline Pathogenicity Pathogens Patients Pediatrics Radiographs Radiography Respiratory tract Respiratory tract diseases Sputum Tumors β Lactamase |
| title | CLINICAL AND MICROBIOLOGICAL FEATURES OF BRANHAMELLA CATARRHALIS BRONCHOPULMONARY INFECTIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T13%3A26%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CLINICAL%20AND%20MICROBIOLOGICAL%20FEATURES%20OF%20BRANHAMELLA%20CATARRHALIS%20BRONCHOPULMONARY%20INFECTIONS&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Slevin,%20NicholasJ&rft.date=1984-04-07&rft.volume=323&rft.issue=8380&rft.spage=782&rft.epage=783&rft.pages=782-783&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(84)91288-1&rft_dat=%3Cproquest_cross%3E2209513599%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2209513599&rft_id=info:pmid/&rft_els_id=S0140673684912881&rfr_iscdi=true |